High-Dose Hydrogen Therapy May Weaken Immune System in Healthy Adults

Authors
Journal
Medical Gas Research
Year
DOI
10.4103/2045-9912.310054
Study Type
Human
Outcome
Negative
Peer Reviewed
Yes
Country
China
Health Condition
Immune System Dysfunction
Body System
Immune System

TL;DR

Breathing in high amounts of hydrogen gas can decrease certain immune cells in healthy people.

Key Finding

Two weeks of high-flow hydrogen inhalation (2-4 hours daily) led to statistically significant decreases in multiple types of immune cells in healthy middle-aged adults, suggesting an inhibitory effect on immune function.

Summary

Researchers studied whether breathing high-flow hydrogen gas affects immune function in healthy middle-aged adults. Twenty participants inhaled hydrogen for 2 to 4 hours daily for 2 weeks. After the study period, several types of immune cells (including helper T cells, natural killer cells, and others) decreased in number compared to before the hydrogen inhalation, suggesting that high-flow hydrogen may reduce immune function.

Practical Takeaway

This small study in healthy adults suggests that very high flow rates of hydrogen gas over extended periods may suppress immune function, which differs from the general safety profile reported in other hydrogen research. However, this is a single, small study with limited details, so more research is needed to understand whether these effects occur at lower doses or in people with health conditions, and whether they have practical health consequences.

Abstract

Hydrogen inhalation therapy has been proven to be safe and effective in disease treatment in multiple clinical reports, but the gas flow rates used in different studies vary greatly. Since there is no upper limit for the safe concentration of hydrogen, this study tested the effects of high-flow (not high concentration) hydrogen inhalation on immune function. From October 2019 to January 2020, 20 adult participants (31-60 years old) were enrolled in a self-controlled study to check the immune function in peripheral blood lymphocyte subsets before and after a 2-week hydrogen inhalation protocol. The participants inhaled hydrogen for 2 or 4 hours each day. After 2 weeks of hydrogen inhalation, statistically significant changes were observed in follicular helper T cells, helper and cytotoxic T cells, natural killer and natural killer T cells, and gamma delta T cells, generally suggesting a decrease in their proportions. These results show that high-flow hydrogen inhalation has an inhibitory effect on the immune function of healthy participants. The study protocol received ethical approval from the Ethics Committee of Fuda Cancer Hospital, Jinan University on December 7, 2018 (approval No. Fuda20181207).